CDCA7L anticorps (AA 381-454) (Biotin)
Aperçu rapide pour CDCA7L anticorps (AA 381-454) (Biotin) (ABIN760438)
Antigène
Voir toutes CDCA7L AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 381-454
-
Réactivité croisée
- Humain, Souris, Rat
-
Homologie
- Dog,Cow,Pig,Horse,Chicken,Rabbit
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human CDCA7L
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
IHC-P 1:200-400
IHC-F 1:100-500 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C for 12 months.
-
Date de péremption
- 12 months
-
-
- CDCA7L (Cell Division Cycle Associated 7-Like (CDCA7L))
-
Autre désignation
- CDCA7L
-
Sujet
-
Synonyms: c Myc Interacting protein JPO2, DKFZp762L0311, RAM2, HR1, JPO2, Protein JPO2, R1 antibody Transcription Factor RAM2.CDA7L_HUMAN
Background: CDCA7L is a member of the CDCA (cell division cycle associated) protein family. Members of this family have expression patterns associated with other known cell cycle genes such as cyclins and CDC genes. CDCA7L plays a role in transcriptional regulation as a repressor that inhibits monoamine oxidase A (MAOA) activity and gene expression by binding to the promoter. It also plays an important oncogenic role in mediating the full transforming effect of MYC in medulloblastoma cells. It is involved in apoptotic signaling pathways and may act downstream of P38-kinase and BCL-2, but upstream of CASP3/caspase-3 as well as CCND1/cyclin D1 and E2F1.
-
ID gène
- 55536
Antigène
-